Laser Therapy Effect on Oral Mucositis in Childhood Acute Lymphoblastic Leukemia Patients
Phase NA Unknown
51 enrolled
INTHEMA
Unknown
2,000 enrolled
Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate
Unknown
1,000 enrolled
Is Ibrutinib-related Atrial Fibrillation Dose Dependent
Unknown
18,000 enrolled
Comparison Between Peribulbar And Sub-tenon Blocks on Oculocardiac Reflex (OCR) During Pediatric Strabismus Surgery
Phase NA Unknown
140 enrolled
Safety and Efficacy of Venetoclax Combination With Decitabine(DEC3-VEN) in the Treatment of AML in the Adult
Phase 2/3 Unknown
40 enrolled
RELAX
Phase 1/2 Unknown
55 enrolled
Physical Therapy in Patients Undergoing Allo-HSCT With cGVHD
Phase NA Unknown
108 enrolled
National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup
Unknown
500 enrolled
SKETCh
Unknown
650 enrolled
Prognostic Value of "CD200" in Hematological Malignancies. Hematological Malignancies Comprise a Group of Malignant Clonal Disorders Arising From the Hematopoietic Tissues , Including Leukemia , Multiple Myeloma , and They Have a High Morbidity and Mortality
Unknown
40 enrolled
Preliminary Assessment of [18F]BL40 in PET/CT Scans
Unknown
30 enrolled
Advancing Chemical and Genomic Strategies for Relapsed/Refractory T-ALL and ETP-ALL
Phase NA Unknown
32 enrolled
Acute Concussion and Melatonin
Phase 2 Unknown
254 enrolled
MPL - NPM
Unknown
30 enrolled
Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours
Phase 2/3 Unknown
30 enrolled
COVIDVAC OH
Unknown
500 enrolled
Safety and Efficacy of LPE in Clearing DSA in Patients Who Received Allo-HSCT
Phase NA Unknown
38 enrolled
DLI-Boost
Phase 3 Unknown
52 enrolled
Turkish Cultural Adaptation, Validity and Reliability of the "Gait Outcomes Assessment List"
Unknown
200 enrolled
Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201)
Unknown
320 enrolled
Venetoclax in Combination With Standard Induction and Consolidation Chemotherapy in Newly Diagnosed Young AML Patients
Unknown
45 enrolled
The Role of NK Cells to Detect Blood Infection in ALL.
Unknown
56 enrolled
Clinical Trial for the Safety and Efficacy of Anti-CD7 CAR-T Cell Therapy for Patients With Relapsed or Refractory CD7 Positive Hematological Malignancy
Phase 1 Unknown
81 enrolled
Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study
Unknown
350 enrolled
MUCOPS
Phase NA Unknown
80 enrolled
Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence
Phase NA Unknown
30 enrolled
Point-of-Care Ultrasound for Pediatric Thoracic Trauma: A Multi-Institutional Trial
Unknown
1,020 enrolled
Venetoclax Plus RIC Regimen Allo-HSCT for Elderly Patients With High-risk Myeloid Malignancies
Phase 2 Unknown
50 enrolled
Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy.
Unknown
954 enrolled
ADLs at the End of Acute Treatment for Childhood Leukemia and Non-Hodgkin Lymphoma
Unknown
20 enrolled
Clinical Study of Venetoclax Combined With CAG in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia
Phase 2 Unknown
52 enrolled
Plerixafor Plus Donor Lymphocyte Infusion for Relapsed Acute Leukemia After Allo-HSCT
Phase 2 Unknown
28 enrolled
Adherence, Viability, Clinical Evolution and Therapeutic Efficacy in Patients Undergoing Bone Marrow Transplantation
Phase NA Unknown
93 enrolled
IRAF-ABLATION Study: a Multicenter International Retrospective Cohort of Patients With BTK Inhibitors-related AF Treated by Catheter Ablation
Unknown
100 enrolled
Prospective, Single-arm, Multicenter Clinical Study on Haploidentical Hematopoietic Stem Cell Transplantation in Patients With MRD Positive CD19+ALL Treated With Conditioning Regimens Containing Blinatumomab
Phase 1 Unknown
31 enrolled
Metabolic Alternation and Clinicohematological Characteristic in Chronic Phase CML in Patient Treated With TKI
Unknown
45 enrolled
A Prospective Clinical Study of Bridging alloHSCT After Treatment With Obinutuzumab in Combination With Chidamide and Venetoclax in RR Ph-ALL and B-cell Lymphoma Patients
Phase 1/2 Unknown
42 enrolled
Evaluation of the Advantage in the Use of Enteral Nutrition in Children Treated for Acute Lymphoblastic Leukemia
Unknown
300 enrolled
Evaluation of Brain Changes in ALL Patients on Therapy
Phase NA Unknown
110 enrolled
MASSAYA
Unknown
181 enrolled
Elattar
Unknown
100 enrolled
Clinical Study of Venetoclax Combined With CACAG Regimen in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
Phase 2 Unknown
200 enrolled
Viale-a
Phase 3 Unknown
154 enrolled
Immune Reconstitution After Allo-HSCT and Blinatumomab
Unknown
20 enrolled
Gastric Residual Volumes in Infants Fed at 4 and 6 Hours Prior to General Anaesthesia
Phase NA Unknown
70 enrolled
IMPROVE
Phase 2 Unknown
31 enrolled
RITII
Phase 2 Unknown
25 enrolled
EDEA
Phase NA Unknown
293 enrolled
MoTD
Phase 2 Unknown
400 enrolled